vs
Side-by-side financial comparison of REGIS CORP (RGS) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
REGIS CORP is the larger business by last-quarter revenue ($57.1M vs $39.6M, roughly 1.4× SBC Medical Group Holdings Inc). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs 0.8%, a 35.1% gap on every dollar of revenue. On growth, REGIS CORP posted the faster year-over-year revenue change (22.3% vs -10.9%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $891.0K). Over the past eight quarters, REGIS CORP's revenue compounded faster (7.8% CAGR vs -15.0%).
REGIS CORPRGSEarnings & Financial Report
Regis Corporation is an American operator of hair salons. As of August 2021, it has 5,563 franchised and 276 company-owned salons. Its headquarters are in Minneapolis, Minnesota.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
RGS vs SBC — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $57.1M | $39.6M |
| Net Profit | $456.0K | $14.2M |
| Gross Margin | — | 73.1% |
| Operating Margin | 10.8% | 32.5% |
| Net Margin | 0.8% | 35.9% |
| Revenue YoY | 22.3% | -10.9% |
| Net Profit YoY | -94.0% | 117.2% |
| EPS (diluted) | $0.16 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $57.1M | $39.6M | ||
| Q3 25 | $59.0M | $43.4M | ||
| Q2 25 | $60.4M | $43.4M | ||
| Q1 25 | $57.0M | $47.3M | ||
| Q4 24 | $46.7M | $44.4M | ||
| Q3 24 | $46.1M | $53.1M | ||
| Q2 24 | $49.4M | $53.1M | ||
| Q1 24 | $49.2M | $54.8M |
| Q4 25 | $456.0K | $14.2M | ||
| Q3 25 | $1.4M | $12.8M | ||
| Q2 25 | $116.5M | $2.5M | ||
| Q1 25 | $250.0K | $21.5M | ||
| Q4 24 | $7.6M | $6.5M | ||
| Q3 24 | $-853.0K | $2.8M | ||
| Q2 24 | $91.2M | $18.5M | ||
| Q1 24 | $-2.3M | $18.8M |
| Q4 25 | — | 73.1% | ||
| Q3 25 | — | 70.6% | ||
| Q2 25 | — | 69.2% | ||
| Q1 25 | — | 79.7% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 81.5% | ||
| Q2 24 | — | 74.2% | ||
| Q1 24 | — | 72.1% |
| Q4 25 | 10.8% | 32.5% | ||
| Q3 25 | 10.0% | 36.6% | ||
| Q2 25 | 12.1% | 33.6% | ||
| Q1 25 | 8.8% | 51.1% | ||
| Q4 24 | 11.8% | 10.6% | ||
| Q3 24 | 4.6% | 26.1% | ||
| Q2 24 | — | 51.4% | ||
| Q1 24 | 8.3% | 44.6% |
| Q4 25 | 0.8% | 35.9% | ||
| Q3 25 | 2.3% | 29.6% | ||
| Q2 25 | 192.9% | 5.7% | ||
| Q1 25 | 0.4% | 45.4% | ||
| Q4 24 | 16.4% | 14.7% | ||
| Q3 24 | -1.9% | 5.3% | ||
| Q2 24 | 184.7% | 34.8% | ||
| Q1 24 | -4.7% | 34.2% |
| Q4 25 | $0.16 | $0.15 | ||
| Q3 25 | $0.49 | $0.12 | ||
| Q2 25 | $43.67 | $0.02 | ||
| Q1 25 | $0.08 | $0.21 | ||
| Q4 24 | $2.71 | $0.05 | ||
| Q3 24 | $-0.36 | $0.03 | ||
| Q2 24 | $38.40 | $0.20 | ||
| Q1 24 | $-1.00 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.4M | $164.1M |
| Total DebtLower is stronger | $113.3M | $42.8M |
| Stockholders' EquityBook value | $188.7M | $248.3M |
| Total Assets | $588.3M | $380.4M |
| Debt / EquityLower = less leverage | 0.60× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.4M | $164.1M | ||
| Q3 25 | $16.6M | $127.4M | ||
| Q2 25 | $17.0M | $152.7M | ||
| Q1 25 | $13.3M | $132.1M | ||
| Q4 24 | $10.2M | $125.0M | ||
| Q3 24 | $6.3M | $137.4M | ||
| Q2 24 | $10.1M | — | ||
| Q1 24 | $5.9M | — |
| Q4 25 | $113.3M | $42.8M | ||
| Q3 25 | $111.3M | $21.1M | ||
| Q2 25 | $110.8M | $7.1M | ||
| Q1 25 | $112.0M | $6.9M | ||
| Q4 24 | $111.5M | $6.6M | ||
| Q3 24 | $95.2M | $823.2K | ||
| Q2 24 | $99.5M | — | ||
| Q1 24 | $179.7M | — |
| Q4 25 | $188.7M | $248.3M | ||
| Q3 25 | $187.6M | $248.0M | ||
| Q2 25 | $185.6M | $244.6M | ||
| Q1 25 | $68.6M | $226.4M | ||
| Q4 24 | $66.7M | $195.1M | ||
| Q3 24 | $56.4M | $205.0M | ||
| Q2 24 | $56.8M | $8.8M | ||
| Q1 24 | $-35.8M | $9.0M |
| Q4 25 | $588.3M | $380.4M | ||
| Q3 25 | $592.1M | $321.4M | ||
| Q2 25 | $599.0M | $315.3M | ||
| Q1 25 | $511.2M | $284.6M | ||
| Q4 24 | $530.1M | $266.1M | ||
| Q3 24 | $508.9M | $296.5M | ||
| Q2 24 | $530.5M | $19.5M | ||
| Q1 24 | $543.7M | $19.8M |
| Q4 25 | 0.60× | 0.17× | ||
| Q3 25 | 0.59× | 0.09× | ||
| Q2 25 | 0.60× | 0.03× | ||
| Q1 25 | 1.63× | 0.03× | ||
| Q4 24 | 1.67× | 0.03× | ||
| Q3 24 | 1.69× | 0.00× | ||
| Q2 24 | 1.75× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.7M | $52.0M |
| Free Cash FlowOCF − Capex | $891.0K | $51.2M |
| FCF MarginFCF / Revenue | 1.6% | 129.3% |
| Capex IntensityCapex / Revenue | 1.4% | 2.0% |
| Cash ConversionOCF / Net Profit | 3.65× | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $14.9M | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7M | $52.0M | ||
| Q3 25 | $2.3M | $-20.9M | ||
| Q2 25 | $6.8M | $-8.3M | ||
| Q1 25 | $6.2M | $1.9M | ||
| Q4 24 | $2.1M | $-7.3M | ||
| Q3 24 | $-1.3M | $5.0M | ||
| Q2 24 | $5.1M | $19.2M | ||
| Q1 24 | $-277.0K | $3.7M |
| Q4 25 | $891.0K | $51.2M | ||
| Q3 25 | $1.9M | $-20.9M | ||
| Q2 25 | $6.2M | $-8.6M | ||
| Q1 25 | $5.9M | $1.7M | ||
| Q4 24 | $1.7M | $-7.9M | ||
| Q3 24 | $-1.4M | $4.6M | ||
| Q2 24 | $5.1M | $18.3M | ||
| Q1 24 | $-326.0K | $3.0M |
| Q4 25 | 1.6% | 129.3% | ||
| Q3 25 | 3.2% | -48.3% | ||
| Q2 25 | 10.3% | -19.9% | ||
| Q1 25 | 10.3% | 3.5% | ||
| Q4 24 | 3.6% | -17.8% | ||
| Q3 24 | -3.0% | 8.7% | ||
| Q2 24 | 10.3% | 34.5% | ||
| Q1 24 | -0.7% | 5.4% |
| Q4 25 | 1.4% | 2.0% | ||
| Q3 25 | 0.7% | 0.1% | ||
| Q2 25 | 0.9% | 0.7% | ||
| Q1 25 | 0.6% | 0.5% | ||
| Q4 24 | 0.9% | 1.3% | ||
| Q3 24 | 0.0% | 0.8% | ||
| Q2 24 | 0.0% | 1.6% | ||
| Q1 24 | 0.1% | 1.3% |
| Q4 25 | 3.65× | 3.66× | ||
| Q3 25 | 1.68× | -1.63× | ||
| Q2 25 | 0.06× | -3.39× | ||
| Q1 25 | 24.80× | 0.09× | ||
| Q4 24 | 0.28× | -1.12× | ||
| Q3 24 | — | 1.77× | ||
| Q2 24 | 0.06× | 1.04× | ||
| Q1 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
